Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
M C BraunC F Strife

Abstract

Membranoproliferative glomerulonephritis (MPGN) is classified as type I, II, or III based on ultrastructural alterations in the glomerular basement membrane. Whereas type II has long been recognized as clinically and pathologically unique, types I and III are often difficult to distinguish and have not been separated in most clinical studies. We compared the course and long-term outcome of patients with types I and III MPGN followed up at this institution since 1960. During this period, 21 patients with type I and 25 patients with type III were followed up for a minimum of 5 years. Patients with types I and III MPGN did not differ in age at apparent onset, age at diagnosis, or interval from apparent onset of symptoms to diagnosis (biopsy). They had similar initial serum C3 and serum albumin levels. Patients with type I had a significantly lower initial mean estimated glomerular filtration rate (GFR(est)) compared with those with type III (99.1 +/- 35.9 versus 131.6 +/- 36. 1 mL/min/1.73 m(2); P < 0.01). Type and duration of therapy, length of follow-up, and frequency of complications of therapy did not differ between groups. There was, however, a significant difference in duration of hypocomplementemia. After 1 year of an alter...Continue Reading

References

Jun 5, 1986·The New England Journal of Medicine·T R WelchC D West
Dec 1, 1983·The American Journal of Medicine·S W ZimmermanU Varanasi
Sep 1, 1984·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A R WatsonR Baumal

❮ Previous
Next ❯

Citations

Jul 24, 2012·Clinical and Experimental Nephrology·Takashi TakeiKosaku Nitta
Apr 16, 2008·Journal of Immunological Methods·Clark D West
Dec 3, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Abdullah SakarcanIsmail Islek
Apr 9, 2016·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Magdalena RiedlChristoph Licht
Jun 28, 2007·Expert Opinion on Investigational Drugs·Timm H Westhoff, Markus van der Giet
Sep 8, 2007·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Luca AresuRenato Zanatta
Mar 12, 2019·Clinical and Experimental Nephrology·Marie NakanoKosaku Nitta
Jul 26, 2002·Journal of the American Society of Nephrology : JASN·John J NearyMichelle P Winn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
J M Bergstein, S P Andreoli
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
M SomersM Kim
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Kikuo IitakaTadasu Sakai
© 2021 Meta ULC. All rights reserved